🔗 Share this article

A shadow market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with numerous of members share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers market the drug there before directing customers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could lead to individuals injecting products of unknown origin.

Some experts stated the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Content Elimination

Based on TikTok, the service has taken down violative content and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also discovered communities with up to 9,000 members selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at residence.

Within minutes of joining one group, a vendor shared contact information, where the majority of transactions occur. The vendor sent an instruction manual and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Details and Costs

Within these communities, messages display black plastic parcels with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has previously encountered individuals injured by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational product not yet approved … may expose users to possibly serious medical dangers”.